Literature DB >> 11514726

Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains.

Naoko Nakagawa1, Ritsuko Kubota1, Toshimasa Nakagawa2, Yoshinobu Okuno1.   

Abstract

To study the neutralizing epitopes of influenza B virus Victoria group strains, two monoclonal antibodies (MAbs) were used to select antigenic variants of the virus. MAbs 10B8 and 8E6 were found to react with B/Victoria group strains in three tests, peroxidase-antiperoxidase staining, haemagglutination inhibition and neutralization tests; no reactivity with B/Yamagata group strains was observed. Analysis of the deduced amino acid sequences of 10B8-induced variants identified a single amino acid deletion at residue 165 or 170, as well as a single amino acid substitution at residues 164 (Asp-->Tyr), 165 (Asn-->Ser or Thr) or 203 (Lys-->Thr or Asn). A single amino acid substitution at residue 241 (Pro-->Ser) was observed in 8E6-induced variants. Three-dimensional analysis showed that the epitopes for both MAbs were situated in close proximity to each other. Since B/Yamagata group strains are characterized by amino acid deletions at residues 164-166, the epitope for MAb 10B8 is strictly specific for B/Victoria group strains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514726     DOI: 10.1099/0022-1317-82-9-2169

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza.

Authors:  Katia Koelle; Priya Khatri; Meredith Kamradt; Thomas B Kepler
Journal:  J R Soc Interface       Date:  2010-03-24       Impact factor: 4.118

2.  Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Jun Suzuoki; Ritsuko Kubota; Shinzo Kobatake; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5.

Authors:  Nobuko Ohshima; Yoshitaka Iba; Ritsuko Kubota-Koketsu; Yoshizo Asano; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

5.  Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.

Authors:  Yoshitaka Iba; Yoshifumi Fujii; Nobuko Ohshima; Tomomi Sumida; Ritsuko Kubota-Koketsu; Mariko Ikeda; Motoaki Wakiyama; Mikako Shirouzu; Jun Okada; Yoshinobu Okuno; Yoshikazu Kurosawa; Shigeyuki Yokoyama
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

6.  Structural basis for the divergent evolution of influenza B virus hemagglutinin.

Authors:  Fengyun Ni; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-08-27       Impact factor: 3.616

7.  Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Akiko Maeda; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Cocirculation and evolution of two lineages of influenza B viruses in europe and Israel in the 2001-2002 season.

Authors:  X Sherry Chi; Trentice V Bolar; Ping Zhao; Ruth Rappaport; Sheau-Mei Cheng
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Emergence of an influenza B virus with antigenic change.

Authors:  Naoko Nakagawa; Souichi Nukuzuma; Shigekazu Haratome; Shosan Go; Toshimasa Nakagawa; Kozaburo Hayashi
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Heterogeneous selective pressure acting on influenza B Victoria- and Yamagata-like hemagglutinins.

Authors:  Baltazar Nunes; Pedro Pechirra; Anabela Coelho; Carlos Ribeiro; Ana Arraiolos; Helena Rebelo-de-Andrade
Journal:  J Mol Evol       Date:  2008-10-08       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.